Press Release

Peripheral Blood Mononuclear Cells Market to Grow with a CAGR of 10.39% through 2028

Increased number of cell therapies for human well-being is expected to drive the growth of global peripheral blood mononuclear cells market in the forecast period.


According to TechSci Research report, “Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global peripheral blood mononuclear cells market stood at USD 235.68 million in 2022 and is anticipated to grow with a CAGR of 10.39% in the period, 2023-2028, The major factors driving the growth of Peripheral Blood Mononuclear Cells Market include increase in number of cell therapies, growing R&D of peripheral blood mononuclear cells and growing usage of peripheral cells in toxicology research.

The peripheral blood mononuclear cells (PBMCs) are used to investigate the effect of food bio-actives on various immune cells. They have a round nucleus, consisting of macrophages, dendritic cells, monocytes, and lymphocytes (T cells, B cells, and NK cells). However, these cells prevent the body by developing antibodies against antigens.

However, one of the restraining factors is ethical and legal considerations. The acquisition of PBMCs involves obtaining blood samples from donors, which raises ethical and legal considerations. Consent from donors, compliance with ethical guidelines, and adherence to privacy regulations are essential. Strict regulatory frameworks and ethical concerns can impose limitations on the collection, storage, and utilization of PBMCs, potentially hindering the growth of global peripheral blood mononuclear cells market. Also, the cost of PBMC isolation and processing is high. The isolation, processing, and storage of PBMCs involve significant costs. Specialized equipment, reagents, and skilled personnel are required for these procedures. Moreover, maintaining optimal storage conditions, such as low-temperature freezers, can further increase the costs.


Browse over 149 market data figures, 14 market data tables spread through 589 Pages, and an in-depth TOC on "Global Peripheral Blood Mononuclear Cells Market"


The global peripheral blood mononuclear cells market is segmented into product, application, technique, source, region, and company.

Based on product, the market is segmented into cryopreserved or frozen PBMC, cultured or fresh PBMC, and peripheral blood mononuclear cell isolation & viability kits. In 2022, cryopreserved or frozen PBMC product segment held the major revenue share i.e., 47.91%. Cryopreserved or frozen PBMCs obtained from human or animal species and are used for long term storage. These cells can be utilized in human immunology. Over the projected period, this segment is expected to increase at a steady rate. The rate of increasing R&D and storage facilities leads to the growth of this segment in PBMCs market.

Based on the application, the market is divided into immunology, hematology, infectious disease, and others. With a market share of 49.25% in 2022, the immunology segment is dominating the global peripheral blood mononuclear cells market. An increase in anti-bodies for the development of the immune system leads to the growth of market.

Based on regional analysis, in terms of revenue share in 2022, North America dominated the global peripheral blood mononuclear cells market by a CAGR of 10.90%. This region's expansion is being fueled by an increasing target population and a growing number of cell therapies. Europe accounted for the second-largest proportion, with significant increase predicted in the future years. During the predicted period, the Asia Pacific region is expected to grow strongly.


The leading companies operating in the Global Peripheral Blood Mononuclear Cells Market are:

  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • ABCAM
  • Biolegend Inc
  • ZEN-Bio Inc
  • DAPCEL, Inc.
  • Creative Bioarray
  • iXCells Biotechnologies USA, LLC
  • Miltenyi Biotec B.V. & CO. KG
  • STEMCELL Technologies Inc.
  • Precision Medicine Group, LLC.
  • StemExpress, LLC
  • RayBiotech Life, Inc.
  • REPROCELL Inc.
  • Cytologics LLC
  • BioIVT LLC
  • Biopredic International
  • Cell Applications, Inc.


Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“Global peripheral blood mononuclear cells market will see a robust growth during the forecast period of 2024-2028. The market for peripheral blood mononuclear cells is expected to develop due to rising research practices, cell-based therapies to either replace or regenerate human cells, tissues, or organs for normal functioning, and increased focus on regenerative medicine. Additionally, the global peripheral blood mononuclear cells market has been fueled by advancements in technology, therapies, and treatments, rising research in Biotechnology and Cell Culture Techniques, supportive government initiatives, and funding.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, and Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Hematology, Infectious Disease, Hematology, and Others), By Techniques (Density Gradient Centrifugation, Leukapheresis, and Others), By Source (Human, Animals), By Region, Competition, Forecast and Opportunities, 2028”, has evaluated the future growth potential of Global Peripheral Blood Mononuclear Cells Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Peripheral Blood Mononuclear Cells Market. 


Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
 [email protected]
Website: 
https://www.techsciresearch.com

Relevant News